7th Sep 2015 07:23
LONDON (Alliance News) - Investment company Kuala Innovations Ltd said Monday it has acquired a 4.9% interest in private company Diabetic Boot Co Ltd for GBP347,324.
Additionally, it has appointed current non-executive director James Mellon as its co-executive chairman.
It bought 25,978 shares at a price of GBP13.37 per share in Diabetic Boot through the issue of 6.9 million shares in Kuala, each with an implied value of 5 pence per share, Kuala said.
Shares in Kuala were down 1.7% at 6.02 pence shortly after market open Monday.
Diabetic Boot is based near Oxford, and its lead product PulseFlow is for the treatment of diabetic foot ulcers.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
KUL.L